In the February 2018 Request for Comment, NIOSH requested comment on a draft Policy and Procedures for developing the List.The draft Policy and Procedures document was developed to formalize the methodology NIOSH uses to guide the addition of hazardous drugs to the List and create a process for requesting the removal from or placement of drugs on the List. The new drafts, entitled the Procedures for Developing the NIOSH List of Hazardous Drugs in Healthcare Settings (Procedures) and the NIOSH List of Hazardous Drugs in Healthcare Settings, 2020 (List) are found in the Supplemental Materials tab of the docket and … Title: NIOSH List of Antineoplastic and Other Hazardous Drugs in Healthcare Settings, 2016 Created Date: 4/6/2017 9:36:11 AM Acetone liquid N/ABlack EPA Repiratory precaution: for all compounding and administration of hazardous liquids/solutions that have inhalation potential, plus cutting or crushing of oral tablets Acitretin Blue Trash Yellow NIOSH Ventilation : for the compounding or preparation of all hazardous drugs The 2016 NIOSH List of Antineoplastic and Drugs that primarily pose a reproductive risk to men and women who are actively trying to conceive and women who are pregnant or breastfeeding Acronyms CSTD = closed system drug-transfer device PPE = personal protective equipment Citation NIOSH . B. NIOSH list of antineoplastic and other hazardous drugs in healthcare settings, 2016. List of Hazardous Drugs. Clarification about hazardous drugs. USP <800> Hazardous Drugs Risk Readiness Checklist 5 List of Hazardous Drugs Completed In Progress To Be Addressed Responsible Indivdual Drugs on the most recent NIOSH list must follow chapter <800> containment requirements: • Any HD and/or active pharmaceutical ingredient (API) is contained within the entity’s HD list By Connor TH, MacKenzieBA, DeBordDG, Trout DB, O’Callaghan JP, OvesenJL, Whittaker C. Cincinnati, OH: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Institute for Occupational Safe ty and Health, DHHS (NIOSH) Publication Number 2020 -xxx • For the purposes of this chapter, the term antineoplastic only refers to antineoplastic drugs included in Table 1 of the most current NIOSH list. Table 1 lists antineoplastic Drugs, Table 2 contains Non-antineoplastic drugs that meet one or more of the NIOSH criteria for a hazardous drug 5 of a hazardous drug. NIOSH list of hazardous drugs in healthcare settings 2020. 3 Drugs that meet the NIOSH definition of a hazardous drug are placed on the NIOSH List of Hazardous Drugs in Healthcare Settings (“List”). NIOSH List of Hazardous Drugs in Healthcare Settings, 2020 1. The List of Oral Dosage Forms That Should Not Be Crushed, commonly referred to as the "Do Not Crush" list, contains medications that should not be crushed because of their special pharmaceutical formulations or characteristics, such as oral dosage forms that are sustained-release in nature. The revised text in <800> will become official on July 1, 2020. Page 11, CAUTION section, states the list is not all-inclusive and drugs that were reviewed, were new drug approvals, or those with new safety-related warnings from the FDA during the period between January … 2. determined to be hazardous The most recent list of hazardous drugs was published by NIOSH in 2016, however a revised list is due out in 2020. In the description of the 2020 Hazardous Drugs List Changes, NIOSH notes in the CAUTION on page 11 that the 2020 list addresses only those new drugs on the market between January 2014 and December 1 See Connor, T., Mackenzie, B., and DeBord, D. (2012). Safety and Health (NIOSH) : Types of hazardous drug Table 4: drugs that were deleted from the 2014 NIOSH hazardous drug list for the 2016 update; however, there are no deletions to report Table 5: provides general guidance for some of the possible scenarios that may be encountered in healthcare settings where hazardous drugs are handled. a hazardous drug. The NIOSH Hazardous Drug list is divided into 5 Tables.
2020 niosh hazardous drug list 2020 pdf